Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Jenscare Scientific Co Ltd
9877Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve (TMVR) repair system, and JensRelive, a TMVR transfemoral system to treat patients with severe mitral regurgitation; MicroFlux, a transcatheter device to treat heart failure with pressured ejection fraction; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it is involved in consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China. Address: Block 5, B Area, Ningbo, China
Analytics
Precio Objetivo de WallStreet
342.61 HKDRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 9877
Análisis de dividendos 9877
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout 9877
Valoración de la acción 9877
Finanzas 9877
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |